Determination of glycated hemoglobin in clinically silent hemoglobin variants

Diabetes/Metabolism Research and Reviews

Volumn 20, Issue 6, 2004, Pages 460-465

  Schnedl, Wolfgang J ^a   Lahousen, Theresa ^a   Lang, Thomas ^a   Lipp, Rainer W ^a   Yonehara, Satoshi ^b   Fukunaga, Satoshi ^b   Imai, Toshihiro ^b   Little, Randie R ^c  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

^b ARKRAY Healthcare Pvt Ltd   (Japan)

^c University of Missouri   (United States)

Author keywords

Boronate affinity HPLC; Enzymatic assay; Glycated hemoglobin; Hemoglobin variants; Immunoassay; ion exchange HPLC

Indexed keywords

HEMOGLOBIN A1C; HEMOGLOBIN D; HEMOGLOBIN DERIVATIVE; HEMOGLOBIN GRAZ; HEMOGLOBIN SHERWOOD FOREST; HEMOGLOBIN VARIANT; UNCLASSIFIED DRUG;

AFFINITY CHROMATOGRAPHY; ARTICLE; BLOOD SAMPLING; CLINICAL LABORATORY; CONTROLLED STUDY; DIABETES MELLITUS; ENZYME ASSAY; HEMOGLOBIN DETERMINATION; HEMOGLOBIN O PADOVA; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; IMMUNOASSAY; INTERMETHOD COMPARISON; ION EXCHANGE CHROMATOGRAPHY; PRIORITY JOURNAL; REFERENCE VALUE;

BORONIC ACIDS; CASE-CONTROL STUDIES; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CHROMATOGRAPHY, ION EXCHANGE; DIABETES MELLITUS, TYPE 2; HEMOGLOBIN A, GLYCOSYLATED; HEMOGLOBINS; HEMOGLOBINS, ABNORMAL; HUMANS; IMMUNOASSAY; VARIATION (GENETICS);

EID: 10644241359     PISSN: 15207552     EISSN: None     Source Type: Journal    
DOI: 10.1002/dmrr.483     Document Type: Article

References (15)

1. American Diabetes Association. Position statement: tests of glycemia in diabetes. Diabetes Care 2003; 26(Suppl. 1): S106-S108.
2. 1c). (Review) Diabetes Metab Res Rev 2001; 17: 94-98.
3. Bry L, Chen PC, Sacks DB. Effects of hemoglobin variants and chemically modified derivatives on assays for glycohemoglobin (Review). Clin Chem 2001; 47: 153-163.
4. Little RR, Rohlfing CL, Wiedmeyer H-M, Myers GL, Sacks DB, Goldstein DE. NGSP Steering Comittee. The National Glycohemoglobin Standardization Program: A five-year progress report. Clin Chem 2001; 47: 1985-1992.
5. 1c) testing (Editorial). Diabetes Care 2000; 23: 265-266.
6. Roberts WL, Barun KD, Brown D, et al. Effects of hemoglobin C and S trait on eight glycohemoglobin methods. Clin Chem 2002; 48: 383-385.
7. Sakurabayashi I, Watano T, Yonehara S, et al. New enzymatic assay for glycohemoglobin. Clin Chem 2003; 49: 269-274.
8. Gibb I, Parnham A, Fonfrede M, Lecock F. Multicenter evaluation of Tosho glycohemoglobin analyzer. Clin Chem 1999; 45 1833-1841.
9. John WG, Weykamp C, Galanello R, Jou JM, Maggio A. Multinational evaluation of the fully automated Arkray HA-8160 Haemoglobin A1c analyzer. (Abstract) Clin Chem Lab Med 2002; 40 S106.
10. 1c determination methods in patients with hemoglobinopathies. Diabetes Care 2000; 23: 339-344.
11. 1) with a new microcolumn procedure: suitability of the technique of assessing the clinical management of diabetes mellitus. Diabetes 1978; 27: 931-937.
12. Sacks DB. Hemoglobin variants and hemoglobin A1c analysis: problem solved? (Editorial) Clin Chem 2003; 49: 1245-1247.
13. 1c with the HPLC Bio-Rad Variant II. J Clin Pathol 2002; 55: 699-703.
14. Alphabetical hemoglobin variant list (Editorial). Hemoglobin 1996; 20: 313-335.
15. 1c and fructosamine. Diabetes Care 2003; 26: 163-167.